receptor antagonist (pKi
values are 8.52, 7.43 and 6.57 for 5-HT2A
receptors respectively). Displays selectivity over 5-HT1
-adrenergic and β
-adrenergic receptors. Displays cardioprotective activity in vivo
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Identification of the binding sites and selectivity of sarpogrelate, a novel 5-HT2 antagonist, to human 5-HT2A, 5-HT2B and 5-HT2C receptor subtypes by molecular modeling.
Rashid et al.
Life Sci., 2003;73:193
Blockade of 5-HT(2A) receptors by sarpogrelate protects the heart against myocardial infarction in rats.
Brasil et al.
Acute effects of sarpogrelate, a 5-HT2A receptor antagonist on cytokine production in endotoxin shock model of rats.